Agonists of PPAR-α, PPAR-γ, and RXR inhibit the formation of foam cells from macrophages in mice with inflammation

Bulletin of Experimental Biology and Medicine

Volumn 144, Issue 5, 2007, Pages 713-716

  Dushkin, M I ^a   Khoshchenko, O M ^b   Posokhova, E N ^a   Schvarts, Y Sh ^b  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b INSTITUTE OF PHYSIOLOGY   (Russian Federation)

Author keywords

Agonists of peroxisome proliferator activated receptors and retinoid X receptors; Foam cells; Inflammation; Macrophages

Indexed keywords

ALITRETINOIN; BEZAFIBRATE; CHOLESTEROL ESTER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR; ROSIGLITAZONE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG MECHANISM; FOAM CELL; IN VITRO STUDY; INFLAMMATION; LIPID STORAGE; LIPOGENESIS; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; RECEPTOR BLOCKING;

ANIMALS; BEZAFIBRATE; CHOLESTEROL; CHOLESTEROL ESTERS; FOAM CELLS; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; PPAR ALPHA; PPAR GAMMA; RETINOID X RECEPTORS; THIAZOLIDINEDIONES; TRETINOIN; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

MUS;

EID: 41749084171     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-007-0413-3     Document Type: Article

References (15)

1. M. I. Dushkin, E. A. Kornyush, L. M. Polyakov, et al., Biokhimiya, 57, 1181-1191 (1992).
2. M. I. Dushkin, O. M. Perminova, A. F. Safina, and N. N. Vol'skii, Zh. Mikrobiol. Epidemiol. Immunol., No. 6, 52-56 (2004).
3. M. I. Dushkin, O. M. Khoshchenko, E. N. Kudimova, and Ya. Sh. Shvarts, Byull. Eksp. Biol. Med., 141, 194-198 (2006).
4. M. S. Brown, Y. K. Ho, and J. L. Goldstein, J. Biol. Chem., 255, No. 19, 9344-9352 (1980).
5. S. Cuzzocrea, B. Pisano, L. Dugo, et al., Intensive Care Med., 30, No. 5, 951-956 (2004).
6. W. Gamble, M. Vaughan, H. S. Kruth, and S. Avigan, J. Lipid Res., 19, No. 8, 1068-1070 (1978).
7. G. S. Getz, Ibid., 46, No. 4, 619-622 (2005).
8. W. Kozak, M. J. Kluger, A. Kozak, et al., Am. J. Physiol. Regul. Integr. Comp. Physiol., 279, No. 2, R455-R460 (2000).
9. A. C. Li, C. J. Binder, A. Gutierrez, et al., J. Clin. Invest., 114, No. 11, 1564-1576 (2004).
10. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, J. Biol. Chem., 193, No. 1, 265-275 (1951).
11. Z. Majawar, H. Rose, M. P. Morrow, et al., PLoS Biology, 4, No. 11, 1970-1983 (2006).
12. M. Ricote, A. F. Valledor, and C. K. Glass, Arterioscler. Tromb. Vasc. Biol., 24, No. 2, 230-258 (2004).
13. D. C. Sheehan and B. B. Hrapchak, Theory and Practice of Histotechnology, Louis, Missouri (1980).
14. D. B. Wilson, D. P. Wyatt, and J. L. Gookin, J. Craniofac. Genet. Dev. Biol., 10, No. 1, 75-81 (1990).
15. J. L. Witztum, J. Clin. Invest., 115, No. 8, 2072-2075 (2005).